C12Y 304/24812
Adamts5 endopeptidase , i.e. aggrecanase 2
Official title: ADAMTS5 endopeptidase (3.4.24.B12), i.e. aggrecanase 2
C12Y304/24812 (Adamts5 endopeptidase , i.e. aggrecanase 2) appears on 3 US grants and 3 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 3
- Assignees
- 1
- Inventors
- 4
- Latest grant
- 15 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Nanocarriers and their processing for diagnostics and therapeutics15 Jul 2025US 12,357,635 B2Rhode Island Hospital
- Nanocarriers and their processing for diagnostics and therapeutics11 Feb 2020US 10,555,948 B2Rhode Island Hospital
- Nanocarriers and their processing for diagnostics and therapeutics3 Oct 2017US 9,775,842 B2Rhode Island Hospital
- Nanocarriers and their processing for diagnostics and therapeutics3 Dec 2020US 2020/0375991 A1Rhode Island Hospital
- Nanocarriers And Their Processing For Diagnostics And Therapeutics12 Jul 2018US 2018/0193344 A1Rhode Island Hospital
- Nanocarriers And Their Processing For Diagnostics And Therapeutics17 Sep 2015US 2015/0258094 A1Rhode Island Hospital
Most cited
By later US patents